Market News
Wednesday, March 23, 2016
BRIEF-Otonomy initiates patient enrollment in second Phase 3 clinical trial
* Otonomy initiates patient enrollment in second Phase 3 clinical trial of OTO-104 in Ménière's disease
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment